Background: Random-pattern flap transfer is commonly used to treat soft-tissue defects. However, flap necrosis remains a serious problem. Naringin accelerates angiogenesis by activating the expression of vascular endothelial growth factor (VEGF). In the present study, we investigated whether naringin improves the survival of random skin flaps.
INTRODUCTION
Flaps are commonly used to remedy cosmetic defects, restore function after traffic accidents and other traumas, and in the aged. Aydin and Liang W used pedicled, nasolabial island flaps to rebuild the nose after removal of nose-tip basal cell carcinomas [1, 2] . Free flap reconstruction has also been employed to treat breast cancer patients [3] . Morris used a perforator flap to repair a large defect on the back [4] . Random skin flaps that are similar to the wound in texture, color, and dermatoglyphic properties are often employed to repair small soft-tissue defects evident after tumor resection. An adequate blood supply is essential for flap survival; the possibility of necrosis (especially complete necrosis) must be considered when designing and placing flaps [5] . Many agents have been reported to improve flap survival by inhibiting inflammation, increasing free-radical scavenging, promoting angiogenesis, and/or expanding the microvascular network. Such materials include VEGF [6] , sildenafil [7] , bezafibrate [8] , aspirin [9] , and some traditional Chinese medicines [10, 11] . Naringin (4', 5, 7-trihydroxy flavanone-7-rhamnoglucoside) is a flavanone glycoside of grapefruit and other citrus fruits that exhibits many pharmacological activities [12, 13] . Naringin inhibits both oxidative stress [14] and the inflammatory response [15] and reduces apoptosis [16] . Naringin is both neuroprotective [17] and hepatoprotective [18] , and it promoted fracture healing in osteoporotic rats [19] . The etiopathogeneses of lung injuries and pulmonary fibrosis feature expression of TNF-α and transforming growth factor-β (TGF-β) [20] . Naringin may stimulate angiogenesis by activating VEGF expression [12, 19, 21] . However, to the best of our knowledge, no study has explored whether naringin improves the survival of random skin flaps. We explore this possibility in the present study.
RESULTS

General observations and survival of flaps
Every flap was monitored by the same experimenter from day 1 to 7 postoperatively and the conditions (flap color, elasticity and necrosis) were recorded. On postoperative day 7, all groups showed well-demarcated borders between the surviving and necrotic parts; the necrotic areas presented dark, hard, and did not bleed when cut, while the surviving areas presented rosy, soft, and bled when cut ( Figure 1 ).
The flap survival portions were 73.89±4.01% in the Naringin-L group, 77.57±3.96% in the Naringin-H group and 50.2±2.23% in the controls (Figure 2 ). In the naringin group, flap survival area was significantly larger than the controls ( ** p < 0.01 vs. the control group).
Histological changes
In order to evaluate the effects of naringin on the thickness of granulation tissue, tissue edema and infiltration of neutrophil cells, flap sections were prepared for HE staining. As demonstrated in Figure 3A , on day 7, the distal areas were morphologically similar in histological terms. All flaps exhibited similar changes in appearance; inflammatory cells infiltration was prominent, as were structural damage and edema. Ninety percent of tissue images revealed degeneration and necrosis of muscle fibers. Area II of the control group showed that many inflammatory cells were detected, while less in the treatment group, especially in the high-dose group, indicating that the inflammatory reaction was less severe in the treated flaps. Besides, the microvascular density (MVD) of area II was 33.38±2.90, 30.44±1.23, 14.04±2.66/mm2 in the Naringin-H groups, Naringin-L groups and control groups, respectively ( Figure 3B ; ** p < 0.01 vs. the control group). In area I, the Naringin group exhibited edema, vascular dilation and inflammatory cells infiltration to a lesser extent than controls. 
Tissue edema
Flap angiography
Through X-ray imaging obtained 7 days postoperatively, the microvascular of flaps were shown clearly. In the treatment group, particularly in the highdose group the microvascular of flaps was greater than that in controls ( Figure 4 ).
VEGF expression
The VEGF expression level in the naringin group was significantly higher than in the controls based on the IA value 4535±230 (Naringin-H), 4167±271 (Naringin-L), 2061±187 (Controls), respectively ( Figure 5 , ** p < 0.01vs. the control group).
Laser doppler imaging
On day 7, the Laser Doppler System was used to evaluate the blood flow of the flap. The blood flow of the middle area was 70.80±11.69 (Control group), 148.37±36.76 (Naringin-L), 159.98±42.67 (Naringin-H), respectively, and the blood flow in the treatment group was significantly larger than in the controls ( Figure 6 , ** p < 0.01vs. the control group).
Proinflammatory cytokines in serum
The ELISA (enzyme linked immunosorbent assay) kits were used to explore the levels of proinflammatory cytokines such as IL-6 and TNF-α in serum, expressing the degree of inflammatory response. Naringin dramatically decreased the levels of IL-6 (46.16±4.39 pg/mL, low-dose group), (38.32±5.90 pg/mL, high-dose group) compared 
Superoxide dismutase activity and malondialdehyde content
The mean SOD activity level in the naringin group was 65.23±4.76 (Naingin-L), 66.32 ±2.87 (Naringin-H) U/mg protein, which was significantly higher than in the controls (28.80±2.33U/mg protein) ( Figure 7C , ** p < 0.01 vs. the control group). The mean MDA level in the naringin-L group (20.08±1.51 nmol/mg protein) and [22] [23] [24] [25] . We found that naringin protected against flap necrosis by inhibiting apoptosis, attenuating the inflammatory response and oxidative stress, and stimulating blood vessel growth.
DISCUSSION
VEGF, a multifunctional growth factor, plays a central role in angiogenesis, promoting neovascularization and endothelial cell proliferation, which in turn improve flap survival [26, 27] . Angiogenesis greatly enhances vasculogenesis by increasing the delivery levels of oxygen, nutrients, and collagen building blocks [28] . Earlier, naringin was found to trigger VEGF synthesis, to enhance angiogenesis, and to improve capillary density in rats with diabetic foot ulcers. The angiogenetic effect was especially marked [12, 29] . We found that, compared with control rats, the IA (integral absorbance) value was markedly increased in the naringin groups, as were the mean vessel density in area II and the vessel numbers revealed by flap angiography and laser Doppler imaging. However, although VEGF expression was greater in the high-dose than in the low-dose naringin group, the improvements in flap survival were similar between the two groups. Naringin indeed promoted angiogenesis, increasing vessel numbers in damaged tissue by enhancing blood supply and VEGF expression. However, angiogenesis mediated by VEGF is a double-edged sword, promoting flap survival on the one hand and facilitating tumor metastasis on the other. Therefore, the use of VEGFenhancing drugs requires further investigation. The pro-inflammatory growth factor TNF-α facilitates release of the inflammatory mediators interleukin (IL)-1, IL-6, and IL-8, aggravating tissue damage and triggering apoptosis. Recently, VEGF was shown to significantly reduce TNF-α expression and inflammation, both in flaps and other ischemic tissues [26, 30] . Inflammation greatly compromises flap survival [31] . The level of MDA (a major marker of lipid peroxidation) directly reflects the extent of tissue injury [32] . SOD, a crucial endogenous anti-oxidase, protects cells from injury caused by toxic oxygen-derived free radicals, and the SOD level is a sensitive indicator of antioxidant status [33] . We found that the oxidative stress level and serum levels of the pro-inflammatory cytokines TNF-α and IL-6 were significantly reduced in the naringin groups compared with the control, suggesting that naringin alleviated inflammation and oxidative stress, thus effectively preventing ischemia-reperfusion injury. The detailed mechanism involved requires further study.
Thus, naringin improved flap survival by inhibiting inflammation and oxidative stress and promoting angiogenesis. In clinical practice, naringin may enhance flap survival. Additional clinical and experimental studies are required. 
Reagents
Naringin was purchased from Sigma Chemical Co. (St Louis, MO, USA). Anti-VEGF (anti-vascular endothelial growth factor) polyclonal antibody (pAb) was obtained from Bioworld (Nanjing, China). SOD and MDA test kits were purchased from Nanjing Jiancheng Biology Institution (Nanjing, China). Rat TNF-α and IL-6 ELISA kits were purchased from Nanjing KeyGEN Biotech (Nanjing, China).
Flap animal model and drug administration
The modified McFarlane flap model (3 × 9cm) was applied to every rat [34] . The area of the dorsum was divided into three equal segments: I, II and III (proximal, intermediate and distal) (Figure 8 ). Following the surgical procedure, all 90 rats were randomly divided into three groups: a 40 mg/kg naringin-treated group (n = 30, low-dose group); an 80 mg/kg naringin-treated group (n = 30, high-dose group) and a 40 mg/kg control group (0.5 % sodium carboxymethylcellulose) (n = 30). For oral administration, naringin was suspended in 0.5 % sodium carboxymethylcellulose. All rats were treated for 7 days. Postoperatively, all rats were housed in an environmentally controlled room, in standard experimental cages individually and fed standard rat chow and water ad libitum. Because of the self-mutilation, all rats were tied with a collar [35] .
Flap survival measurement
The surviving area of each flap was observed macroscopically during the injection and the appearance, tissue elasticity and hair condition were assessed. After 7 days, we measured the surviving area and total area of each flap using transparent cellophane and the weights of the flap using an electronic scale; the surviving area was calculated as a percentage [8] . The following formula was used to quantify the results: extent of the viable area × 100/the total area (viable and ischemic) [24] .
Histological staining
After all rats were sacrificed, three samples (size in 1×1cm) of the centre flap tissue were harvested from each area, fixed in 4% paraformaldehyde, and routine procedures were performed. Paraffin blocks were cut into 4 μm slices, and stained with hematoxylin and eosin. The Olympus BH51 light microscope (Olympus Corporation, Tokyo, Japan; ×100 magnification) was used to evaluate the condition of tissue edema, the thickness of granulation tissue and count the number of neutrophil cells. Furthermore, in order to comprehend the condition of microvascular density, we also calculated the microvessel number in each unit area(/ mm 2 ).
Tissue edema measurements
After executing the rats, we weighed flap tissue using an electronic scale, and dehydrated using an autoclave with the temperature of 50°C. In order to obtain a constant weight, all samples were weighed daily and until the weight did not change for 2 days. Water content reflected the degree of edema. The percent water content was determined by the following equation: Tissue% water content = ([wet weight-dry weight]/ wet weight)×100%.
Flap angiography
Using a 24-gauge intravenous catheter based on a modified lead oxide-gelatin inoculability tip, ten rats choosing from every group sustained whole-body angiography at 7 days after the operation [36] . Heparin saline (1%, 1.5 mL) was injected to the right carotid artery and then the contrast medium (150 mL/kg) consisted of water, lead oxide and gelatin, was followed. After fixation overnight, we radiographed the flap using an X-ray machine (54 kVp, 40 mA, 100-second exposure).
Laser doppler imaging
All animals were performed using a laser Doppler imaging system (Lisca PIMII, Stockholm, Sweden) on the day of sacrifice. The blood perfusion monitor (PeriFlux System 5000; PERIMED, Järfälla, Sweden) began one hour after stabilization. The second choke zone was inspected for 1 minute. The mean blood flow was expressed as perfusion units [37] .
Immunohistochemical staining
Immunohistochemical staining was conducted for VEGF using the streptavidin-peroxidase method [38] . Flap tissues were imaged at ×400 magnification using a DP2-TWAN image-acquisition system (Olympus Corp., Tokyo, Japan). Images were saved using Image-Pro Plus software, version 6.0 (Media Cybernetics, Rockville, MD) and the VEGF expression levels was detected by the IA values. www.impactjournals.com/oncotarget
SOD activity and mda content
Ten tissue samples (5 × 5 mm) were gained from Areas II at 7 days after the operation, and then a series of procedures were carried out including weighing, homogenizing and diluting. SOD activity was measured by the oxidase enzymatic method, and MDA level was gauged through an approach triggered by a reaction with thiobarbituric acid at 90 to 100°C [39] .
Determination of cytokines in serum by ELISA
According to the manufacturer's instructions, the ELISA kits were applied to measure the levels of IL-6 and TNF-α.
Statistical analysis
The SPSS software (ver.20.0; SPSS Inc., Chicago, IL) was used to statistical analyses and all values were marked as mean ± SD. Multiple comparisons between groups were using one-way ANOVA and Tukey's post hoc test. P values < 0.05 were considered to indicate statistical significance.
Abbreviations VEGF = vascular endothelial growth factor; SOD = measuring superoxide dismutase; MDA = malondialdehyde; TNF-α = tumor necrosis factor-α; TGF-β = transforming growth factor-β; MVD = microvascular density; HE = hematoxylin and eosin; IA = integral absorbance; IL-1= interleukin-1; IL-6 = interleukin-6; IL-8 = interleukin -8; ELISA = enzyme linked immunosorbent assay; ANOVA = analysis of variance.
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